Clinical aspects of drug reactions in hereditary hepatic porphyria.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000208:Acute Disease; D000311:Adrenal Glands / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000503:physiopathology; D001786:Blood Glucose / Q000032:analysis; D003907:Dexamethasone / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D008107:Liver Diseases / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D010243:Paralysis / Q000503:physiopathology; D011164:Porphyrias / Q000145:classification / Q000235:genetics* / Q000378:metabolism* / Q000503:physiopathology; D011773:Pyruvates / Q000097:blood; D014882:Water-Electrolyte Balance
D015065:17-Hydroxycorticosteroids; D001786:Blood Glucose; D007328:Insulin; D007773:Lactates; D011773:Pyruvates; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D005947:Glucose; D008797:Metyrapone